Biotech2 hours ago
Sartorius Stedim Biotech Maintains Growth Momentum in H1 2026
Sartorius Stedim Biotech reported solid H1 2026 results, with revenue reaching €1.527 billion and EBITDA rising to €479 million. Growth was driven by recurring demand and...